150 related articles for article (PubMed ID: 18298087)
1. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).
Johnson TM; Antrobus R; Johnson LN
Biochemistry; 2008 Mar; 47(12):3688-96. PubMed ID: 18298087
[TBL] [Abstract][Full Text] [Related]
2. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
Shan HM; Shi Y; Quan J
ChemMedChem; 2015 Jan; 10(1):158-63. PubMed ID: 25196850
[TBL] [Abstract][Full Text] [Related]
3. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.
García-Alvarez B; de Cárcer G; Ibañez S; Bragado-Nilsson E; Montoya G
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3107-12. PubMed ID: 17307877
[TBL] [Abstract][Full Text] [Related]
4. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting.
Hanisch A; Wehner A; Nigg EA; Silljé HH
Mol Biol Cell; 2006 Jan; 17(1):448-59. PubMed ID: 16267267
[TBL] [Abstract][Full Text] [Related]
5. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.
Elia AE; Cantley LC; Yaffe MB
Science; 2003 Feb; 299(5610):1228-31. PubMed ID: 12595692
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
Yun SM; Moulaei T; Lim D; Bang JK; Park JE; Shenoy SR; Liu F; Kang YH; Liao C; Soung NK; Lee S; Yoon DY; Lim Y; Lee DH; Otaka A; Appella E; McMahon JB; Nicklaus MC; Burke TR; Yaffe MB; Wlodawer A; Lee KS
Nat Struct Mol Biol; 2009 Aug; 16(8):876-82. PubMed ID: 19597481
[TBL] [Abstract][Full Text] [Related]
7. Polo-box domains confer target specificity to the Polo-like kinase family.
van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS.
Vitour D; Dabo S; Ahmadi Pour M; Vilasco M; Vidalain PO; Jacob Y; Mezel-Lemoine M; Paz S; Arguello M; Lin R; Tangy F; Hiscott J; Meurs EF
J Biol Chem; 2009 Aug; 284(33):21797-21809. PubMed ID: 19546225
[TBL] [Abstract][Full Text] [Related]
9. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
Bibi N; Parveen Z; Rashid S
PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions.
Reindl W; Yuan J; Krämer A; Strebhardt K; Berg T
Chem Biol; 2008 May; 15(5):459-66. PubMed ID: 18482698
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of Polo-like kinases.
Lowery DM; Lim D; Yaffe MB
Oncogene; 2005 Jan; 24(2):248-59. PubMed ID: 15640840
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the polo-box domain of human Polo-like kinase 2.
Kim JH; Ku B; Lee KS; Kim SJ
Proteins; 2015 Jul; 83(7):1201-8. PubMed ID: 25846005
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.
Niiya F; Tatsumoto T; Lee KS; Miki T
Oncogene; 2006 Feb; 25(6):827-37. PubMed ID: 16247472
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain.
Park JE; Kim TS; Kim BY; Lee KS
Cell Cycle; 2015; 14(22):3624-34. PubMed ID: 26513691
[TBL] [Abstract][Full Text] [Related]
16. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate.
Lowery DM; Clauser KR; Hjerrild M; Lim D; Alexander J; Kishi K; Ong SE; Gammeltoft S; Carr SA; Yaffe MB
EMBO J; 2007 May; 26(9):2262-73. PubMed ID: 17446864
[TBL] [Abstract][Full Text] [Related]
17. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
Scharow A; Knappe D; Reindl W; Hoffmann R; Berg T
Chembiochem; 2016 Apr; 17(8):759-67. PubMed ID: 26634982
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
Reindl W; Strebhardt K; Berg T
Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.
Cucchi U; Gianellini LM; De Ponti A; Sola F; Alzani R; Patton V; Pezzoni A; Troiani S; Saccardo MB; Rizzi S; Giorgini ML; Cappella P; Beria I; Valsasina B
Anticancer Res; 2010 Dec; 30(12):4973-85. PubMed ID: 21187478
[TBL] [Abstract][Full Text] [Related]
20. Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation.
Kang YH; Park JE; Yu LR; Soung NK; Yun SM; Bang JK; Seong YS; Yu H; Garfield S; Veenstra TD; Lee KS
Mol Cell; 2006 Nov; 24(3):409-22. PubMed ID: 17081991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
